Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 21, 2016
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic DiseasesNabil K El Ayoubi, Samia J Khoury
BMC Medical Imaging|August 27, 2025
The effect of lesion filling on brain age estimation in multiple sclerosisSalem Hannoun, Grace Fayad, Nabil K El Ayoubi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 11, 2022
Toxocara infection in the differential diagnosis of multiple sclerosis in the Middle EastMarwa Baalbaki, Mayssam El Najjar, Samir Atweh, et al.
Multiple Sclerosis and Related Disorders|September 16, 2022
Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional studyNabil K El Ayoubi, Hussein Moussa, Antoine Younes, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 13, 2022
Rate of Retinal Layer Thinning as a Biomarker for Conversion to Progressive Disease in Multiple SclerosisNabil K El Ayoubi, Hadi M Sabbagh, Nicole Bou Rjeily, et al.
Journal of Neurology|August 22, 2016
Retinal measures correlate with cognitive and physical disability in early multiple sclerosisNabil K El Ayoubi, Stephanie Ghassan, Marianne Said, et al.
Clinical Immunology (Orlando, Fla.)|May 25, 2017
Effect of vitamin D replacement on immunological biomarkers in patients with multiple sclerosisMay F Mrad, Nabil K El Ayoubi, Maria O Esmerian, et al.
Multiple Sclerosis and Related Disorders|May 29, 2021
Effect of fingolimod vs interferon treatment on OCT measurements and cognitive function in RRMSNabil K El Ayoubi, Sarah W Bou Reslan, Marwa M Baalbaki, et al.
Journal of Clinical Medicine|April 26, 2025
Clinical Characteristics, MRI Findings, Disease Progression, and Management of Neuro-Behçet's Disease: A Retrospective Study in LebanonNadia Chamoun, Martine Elbejjani, Nabil K El Ayoubi, et al.
Pageof 3